Advertisement
Home »

Safety of SGLT2 Inhibitors in Three Chronic Diseases.

Apr 03, 2023

ABOUT THE CONTRIBUTORS

  • Shiyao Ge

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University.

    Hebei Province Key Laboratory of Environment and Human Health.

    Ruobin Liu

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University.

    Hebei Province Key Laboratory of Environment and Human Health.

    Yucheng Mao

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University.

    Hebei Province Key Laboratory of Environment and Human Health.

    Chang Geng

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University.

    Hongfei Wang

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University.

    Kai Song

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University.

    Qing-Bao Tian

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University.

    Hebei Province Key Laboratory of Environment and Human Health.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement